Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 3Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Lymphoma 18Lymphoma, Non-Hodgkin 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Hodgkin Disease 11Lymphoma, Large B-Cell, Diffuse 9Central Nervous System Neoplasms 9Leukemia, Myeloid, Acute 8Neuroblastoma 7Multiple Myeloma 7Leukemia 7Brain Neoplasms 7Small Cell Lung Carcinoma 6Sarcoma 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, B-Cell, Marginal Zone 4Carcinoma, Non-Small-Cell Lung 4Burkitt Lymphoma 4Testicular Neoplasms 3Teratoma 3Rhabdoid Tumor 3Medulloblastoma 3Lung Neoplasms 3Astrocytoma 3Waldenstrom Macroglobulinemia 2Testicular Germ Cell Tumor 2Rhabdomyosarcoma 2Recurrence 2

Interventions

Temozolomide 45Radiotherapy 16Carboplatin 15Irinotecan 12Carmustine 12Bevacizumab 12Filgrastim 10Vincristine 9Surgical Procedures, Operative 9Magnetic Resonance Spectroscopy 9Procarbazine 7Peripheral Blood Stem Cell Transplantation 6Imatinib Mesylate 6Erlotinib Hydrochloride 6temsirolimus 5sargramostim 5O(6)-benzylguanine 5Lomustine 5Flucytosine 5Etoposide 5Thiotepa 4Sirolimus 4Cyclophosphamide 4aldesleukin 3Thalidomide 3Surveys and Questionnaires 3Sunitinib 3Radiotherapy, Intensity-Modulated 3Radiation 3Polymerase Chain Reaction 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Oligodendroglioma × etoposide phosphate × Clear all
NCT00303849 2022-03-17

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors

OHSU Knight Cancer Institute

Phase 1/2 Completed
33 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡